Add this: Walgreens better understand who they sell the PBM to. The Data base of Rx patterns/outcome reviews could be damaging to geo. retail competition.
I would say that the PBM never was profitable. It should be interesting to see what they get for it - if they even say. Might find out in a SEC filing but not in a PR, IMO. We'll see.